Interview with the CEO and Director: Motus GI Holdings, Inc. (NASDAQ:MOTS)
Timothy P. Moran is Chief Executive Officer and Director of Motus GI Holdings, Inc. Mr. Moran has served as Chief Executive Officer since October 1, 2018. Prior to joining Motus GI, from 2015 to September 2018, Mr. Moran served as President of the Americas, ConvaTec Group Plc (LON:CTEC) — “ConvaTec” — an international medical products and technologies company, offering products and services in the areas of wound and skin care, ostomy care, continence and critical care and infusion devices. Prior to his employment at ConvaTec, Mr. Moran held roles in sales, marketing and general management over the course of 18 years at Covidien plc — “Covidien” — an Irish-headquartered global health care products company and manufacturer of medical devices and supplies. While at Covidien, until 2015, Mr. Moran served simultaneously as VP and General Manager of both the SharpSafety and Monitoring & Operating Room divisions. Following the 2015 acquisition of Covidien by Medtronic (NYSE:MDT), Mr. Moran was named the Global Vice President and General Manager of the Patient Care and Safety Division. Mr. Moran also served on the CEO Advisory Council for Advanced Medical Technology Association — AdvaMed — a medical device trade association. Mr. Moran earned a B.A. in organizational communication at The State University of New York at Geneseo. Mr. Moran was selected as a director because of his broad commercial experience and leadership in the medical technology sector. Profile
Word count: 3,581
TWST: Please give us an overview of Motus GI Holdings.
Mr. Moran: Motus GI is a medical device company, and we're focused on technology that